COFEPRIS advertising permit
Number 2615052002A00079. It identifies the center’s health advertising.
The laboratory
Clinical science in the service of a diagnosis that can be defended.
The Santa Fe Laboratory exists to evaluate dysautonomias and movement disorders with reproducible protocols, in children, adolescents, and adults in Mexico and Latin America, without lowering the international standard. The family is part of the process.
Clinical direction
Daniel Rebolledo García, M.D.
Neurologist · Internal medicine
Director of the Autonomic and Movement Disorders Clinical Research Laboratory Santa Fe, and a neurohospitalist in Mexico City.
M.D., Universidad Autónoma del Estado de México. Residencies in Internal Medicine and Neurology at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Clinical fellowship in neurodegenerative disease and movement disorders at the Instituto Nacional de Neurología y Neurocirugía.
Post-doctoral research fellowship at the Dysautonomia Center, NYU Grossman School of Medicine, and an MDS-PAS visiting traineeship at the University of Cincinnati Movement Disorders Clinic.
His clinical and research work focuses on neurogenic orthostatic hypotension, pure autonomic failure, synucleinopathy phenoconversion, and the standardization of autonomic testing for Latin American settings.
The clinical team
Institutional identity
Notice of operation
Procedure COFEPRIS-05-036, intake number 2515055036X01491, filed 27 October 2025. Neurology office registered in Toluca (SCIAN 621113). It does not by itself cover the Santa Fe or Pachuca sites.
Professional licenses
Physician license (cédula) 09619992 (UAEMex). Neurology specialty license 14013199. Verifiable in Mexico’s National Register of Professionals.
Sanitary officer
Daniel Rebolledo García, M.D., neurologist and internist. Laboratory director and neurohospitalist in Mexico City.
Nature of the center
A private clinical research laboratory. We are not SSA, IMSS, or ISSSTE. This website does not host a medical record.
Lines of work
01
Standardized autonomic testing
Tilt-table studies, cardiovascular responses, and non-invasive monitoring protocols adapted to real clinical practice.
02
Synucleinopathies and phenoconversion
Pure autonomic failure, nOH, and the transition toward parkinsonism or MSA in Mexican cohorts.
03
Latin American phenotypes
Clinical research that is relevant to the region, held to the same standard as referral centers elsewhere.
In Science We Trust